Category Archives: Pharmaceuticals
Sanofi, Boehringer to Swap Assets
Sanofi agreed to a €22.8 billion ($25.1 billion) asset swap with Germany’s Boehringer Ingelheim GmbH that purports to boost the French drugmaker’s business in selling over-the-counter drugs. Sanofi will trade its animal-health business (Merial), valued at €11.4 billion, for Boehringer’s €6.7 billion … Continue reading
Posted in Miscellaneous, Pharmaceuticals, Uncategorized
Leave a comment
Merck to Acquire IOMet Pharma
Merck has agreed to pay up to $400 million to acquire IOmet Pharma, a Scottish company that specializes in the development of small molecule-based cancer treatments. IOmet will operate as a division of Merck. The acquisition will include IOmet’s pre-clinical pipeline … Continue reading
GSK to Buy BMS’s HIV Portfolio
Drug giant GlaxoSmithKline has reached a deal to acquire Bristol-Myers Squibb’s HIV portfolio. GSK will pay $350 million up front and could pay an additional $1 billion depending on developmental and sales milestones. GSK did the deal through its subsidiary … Continue reading
AMA Calls for Ban on DTC Pharma Advertising
This past Tuesday, the American Medical Association (“AMA”) called for a ban (in the U.S.) of direct-to-consumer (“DTC”) advertising of prescription pharmaceuticals and implantable medical devices. The AMA cites its belief that DTC advertising contributes to the growing cost of … Continue reading
Posted in Pharmaceuticals, Uncategorized
Leave a comment
Ipsen & Telesta Reach Deal
Ipsen and Telesta Therapeutics Inc. announced yesterday that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the treatment of high risk non-muscle invasive bladder cancer (NMIBC) in all countries of the world, … Continue reading
Teva to Acquire Allergan’s Generic Business
Teva Pharmaceuticals is buying Allergan’s generic drug business for $40.5 billion. The Israeli pharmaceutical signed an agreement on 27 July for Allergan Generics and withdrew its plans to acquire Mylan’s business. Under the new agreement, Teva will pay Allergan $33.75 … Continue reading
Posted in Pharmaceuticals
Leave a comment
Mathew Lombard to Speak at PTMG Meeting
Lombard & Geliebter partner, Mathew Lombard, will be speaking at this year’s annual PTMG meeting in Warsaw, Poland. He will be speaking on Thursday, 1 October 2015 on the topic of Business & Trade Secrets, from the U.S. perspective. For … Continue reading
Darren Geliebter
Mathew Lombard
THE PRINCIPAL REGISTER 